AIP
EXAS

Ameritas Investment Partners’s Exact Sciences EXAS Stock Holding History

Ameritas Investment Partners’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-10,005
Closed -$404K – 3016
2018
Q1 		$404K Hold
10,005
– – 0.02% 806
2017
Q4 		$526K Buy
10,005
+565
+6% +$30.2K 0.02% 734
2017
Q3 		$395K Sell
9,440
-200
-2% -$8.05K 0.02% 802
2017
Q2 		$341K Buy
9,640
+511
+6% +$15.8K 0.02% 841
2017
Q1 		$216K Buy
9,129
+7,484
+455% +$148K 0.01% 1012
2016
Q4 		$21K Hold
1,645
– – ﹤0.01% 1167
2016
Q3 		$30K Buy
1,645
+745
+83% +$13.1K ﹤0.01% 1136
2016
Q2 		$11K Hold
900
– – ﹤0.01% 1121
2016
Q1 		$6K Hold
900
– – ﹤0.01% 1145
2015
Q4 		$8K Hold
900
– – ﹤0.01% 1133
2015
Q3 		$16K Sell
900
-6,862
-88% -$158K ﹤0.01% 1052
2015
Q2 		$230K Buy
+7,762
New +$195K 0.02% 923
2015
Q1 		– Sell
-7,495
Closed -$206K – 1212
2014
Q4 		$206K Buy
+7,495
New +$182K 0.01% 975

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ameritas Investment Partners's EXAS Position: Q2 2018 in Review

Ameritas Investment Partners sold out of Exact Sciences (EXAS) in Q2 2018, closing a stake of 10,005 shares — an estimated $404K sold.

Ameritas Investment Partners first reported a position in EXAS in Q4 2014 and held it in 13 quarters. The position peaked at $526K in Q4 2017. 349 funds tracked by Wall St. Rank hold EXAS as of Q2 2018.

  • Ameritas Investment Partners reported no remaining Exact Sciences position as of Q2 2018 after selling out during the quarter.
  • Ameritas Investment Partners sold 10,005 Exact Sciences shares in Q2 2018, an estimated $404K.
  • Ameritas Investment Partners first reported a position in Exact Sciences in Q4 2014 and held it in 13 quarters.
  • Ameritas Investment Partners's Exact Sciences position peaked at $526K in Q4 2017.
  • 349 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2018.

Based on Ameritas Investment Partners's 13F filing for Q2 2018, filed 13 Aug 2018.